| Targeting nuclear factor-kappa B to overcome resistance to chemotherapy P Godwin, AM Baird, S Heavey, MP Barr, KJ O’byrne, K Gately Frontiers in oncology 3, 120, 2013 | 312 | 2013 |
| Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography N Al-Sarraf, R Aziz, K Gately, J Lucey, L Wilson, E McGovern, V Young European journal of cardio-thoracic surgery 33 (1), 104-109, 2008 | 207 | 2008 |
| Strategies for co-targeting the PI3K/AKT/mTOR pathway in NSCLC S Heavey, KJ O’Byrne, K Gately Cancer treatment reviews 40 (3), 445-456, 2014 | 168 | 2014 |
| Clinical implication and prognostic significance of standardised uptake value of primary non-small cell lung cancer on positron emission tomography: analysis of 176 cases N Al-Sarraf, K Gately, J Lucey, R Aziz, K Doddakula, L Wilson, ... European journal of cardio-thoracic surgery 34 (4), 892-897, 2008 | 134 | 2008 |
| Targeting the fibroblast growth factor receptor family in cancer N Hallinan, S Finn, S Cuffe, S Rafee, K O’Byrne, K Gately Cancer treatment reviews 46, 51-62, 2016 | 127 | 2016 |
| Predictors of acute renal failure requiring renal replacement therapy post cardiac surgery in patients with preoperatively normal renal function K Doddakula, N Al-Sarraf, K Gately, A Hughes, M Tolan, V Young, ... Interactive cardiovascular and thoracic surgery 6 (3), 314-318, 2007 | 117 | 2007 |
| Lymph node staging by means of positron emission tomography is less accurate in non-small cell lung cancer patients with enlarged lymph nodes: Analysis of 1145 lymph nodes N Al-Sarraf, K Gately, J Lucey, L Wilson, E McGovern, V Young Lung Cancer 60 (1), 62-68, 2008 | 105 | 2008 |
| Global analysis of serum microRNAs as potential biomarkers for lung adenocarcinoma S Rani, K Gately, J Crown, K O’Byrne, L O’Driscoll Cancer biology & therapy 14 (12), 1104-1112, 2013 | 94 | 2013 |
| Vaping and lung cancer–A review of current data and recommendations D Bracken-Clarke, D Kapoor, AM Baird, PJ Buchanan, K Gately, S Cuffe, ... Lung Cancer 153, 11-20, 2021 | 92 | 2021 |
| Anti-cancer effects of baicalein in non-small cell lung cancer in-vitro and in-vivo MC Cathcart, Z Useckaite, C Drakeford, V Semik, J Lysaght, K Gately, ... BMC cancer 16, 1-13, 2016 | 83 | 2016 |
| Thymidine phosphorylase in cancer; enemy or friend? YY Elamin, S Rafee, N Osman, KJ O′ Byrne, K Gately Cancer Microenvironment 9, 33-43, 2016 | 80 | 2016 |
| Prognostic and therapeutic relevance of FLIP and procaspase-8 overexpression in non-small cell lung cancer JS Riley, R Hutchinson, DG McArt, N Crawford, C Holohan, I Paul, ... Cell death & disease 4 (12), e951-e951, 2013 | 78 | 2013 |
| Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer DS O'Callaghan, E Rexhepaj, K Gately, L Coate, D Delaney, ... European Respiratory Journal 46 (6), 1762-1772, 2015 | 73 | 2015 |
| Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer MP Barr, SG Gray, K Gately, E Hams, PG Fallon, AM Davies, DJ Richard, ... Molecular cancer 14, 1-16, 2015 | 73 | 2015 |
| PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer S Luszczak, C Kumar, VK Sathyadevan, BS Simpson, KA Gately, ... Signal transduction and targeted therapy 5 (1), 7, 2020 | 71 | 2020 |
| Expression of CDCA3 is a prognostic biomarker and potential therapeutic target in non–small cell lung cancer MN Adams, JT Burgess, Y He, K Gately, C Snell, SD Zhang, JD Hooper, ... Journal of Thoracic Oncology 12 (7), 1071-1084, 2017 | 70 | 2017 |
| High coexpression of both EGFR and IGF1R correlates with poor patient prognosis in resected non–small-cell lung cancer K Gately, L Forde, S Cuffe, R Cummins, EW Kay, F Feuerhake, KJ O'Byrne Clinical lung cancer 15 (1), 58-66, 2014 | 69 | 2014 |
| Examination of thromboxane synthase as a prognostic factor and therapeutic target in non-small cell lung cancer MC Cathcart, K Gately, R Cummins, E Kay, KJ O'Byrne, GP Pidgeon Molecular cancer 10, 1-14, 2011 | 62 | 2011 |
| Procaspase 8 overexpression in non-small-cell lung cancer promotes apoptosis induced by FLIP silencing TR Wilson, KM Redmond, KM McLaughlin, N Crawford, K Gately, ... Cell Death & Differentiation 16 (10), 1352-1361, 2009 | 56 | 2009 |
| The role of the molecular footprint of EGFR in tailoring treatment decisions in NSCLC K Gately, J O'Flaherty, F Cappuzzo, R Pirker, K Kerr, K O'Byrne Journal of clinical pathology 65 (1), 1-7, 2012 | 52 | 2012 |
